Journal article
A Prospective Randomized Trial of Imipenem‐Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra‐Abdominal and Pelvic Infections
Abstract
OBJECTIVE: A Canadian multicentre clinical trial in the treatment of intra-abdominal and pelvic infections to compare the efficacy and safety of monotherapy using imipenem-cilastatin (imipenem) (500 mg intravenously every 6 h) versus combination therapy with clindamycin/tobramycin (clindamycin 600 mg intravenously every 6 h and tobramycin 1.7 mg/kg intravenously every 8 h).
METHODS: Two hundred and fifty patients were entered (88 definite and …
Authors
Mandell LA; Turgeon PL; Ronalds AR; Group TCCT
Journal
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol. 4, No. 5, pp. 279–287
Publisher
Wiley
Publication Date
1 1993
DOI
10.1155/1993/567478
ISSN
1712-9532